ProKidney (PROK) Stock Chart & Stock Price History $4.54 -0.64 (-12.36%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$4.81 +0.27 (+5.88%) As of 07:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ProKidney Stock Price Performance The ProKidney (PROK) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 93.19%, with a year-to-date return of 168.64%. In the past month, the stock has increased 441.57%, reflecting recent market activity. As of the latest close, ProKidney traded at $4.54 with a market cap of $1.33 billion and volume of 17.60 million shares. Receive PROK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProKidney and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.61%1 Month Performance+441.57%3 Month Performance+513.51%Year-To-Date Performance+168.64%1 Year Performance+93.19% PROK Stock Chart for Monday, July, 14, 2025 PROK Chart by TradingView ProKidney Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$5.18$4.54-12.36%$5.45$4.4817.60 million shs$1.33 billion07/10/2025$4.34$5.18+19.35%$5.95$4.5073.05 million shs$1.52 billion07/09/2025$3.73$4.34+16.35%$7.13$4.18209.67 million shs$1.27 billion07/08/2025$0.61$3.73+515.00%$4.92$1.02338.88 million shs$1.09 billion07/07/2025$0.69$0.61-11.97%$0.65$0.59819,564 shs$177.52 million07/04/2025$0.69$0.69$0.73$0.591.54 million shs$201.67 million07/03/2025$0.58$0.69+19.06%$0.73$0.591.54 million shs$201.67 million07/02/2025$0.57$0.58+2.39%$0.61$0.55459,666 shs$169.39 million07/01/2025$0.59$0.57-4.54%$0.61$0.551.04 million shs$165.43 million06/30/2025$0.67$0.59-11.46%$0.70$0.541.61 million shs$173.31 million Get the Latest News and Ratings for PROK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProKidney and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.72$0.67-7.50%$0.74$0.6712.36 million shs$195.73 million06/26/2025$0.77$0.72-6.24%$0.79$0.69875,901 shs$211.59 million06/25/2025$0.65$0.77+19.50%$0.90$0.643.07 million shs$225.67 million06/24/2025$0.61$0.65+6.47%$0.73$0.641.77 million shs$188.85 million06/23/2025$0.66$0.61-8.20%$0.73$0.612.06 million shs$177.38 million06/20/2025$0.70$0.66-5.20%$0.77$0.661.80 million shs$193.21 million06/19/2025$0.70$0.70$0.93$0.691.28 million shs$203.81 million06/18/2025$0.86$0.70-18.84%$0.93$0.691.28 million shs$203.81 million06/17/2025$0.99$0.86-13.02%$1.02$0.861.16 million shs$251.11 million06/16/2025$0.84$0.99+17.65%$1.01$0.84756,622 shs$288.69 million06/13/2025$0.90$0.84-6.44%$0.92$0.83297,259 shs$245.37 million Related Companies PCVX Stock Price Chart ADMA Stock Price Chart CYTK Stock Price Chart KRYS Stock Price Chart AKRO Stock Price Chart ZLAB Stock Price Chart RARE Stock Price Chart PTCT Stock Price Chart ACLX Stock Price Chart MRUS Stock Price Chart Receive PROK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProKidney and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PROK) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProKidney With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
